UPDATE: Goldman Sachs Starts Athira Pharma (ATHA) at Neutral
Tweet Send to a Friend
(Updated - December 15, 2021 4:42 AM EST)
Goldman Sachs analyst Corinne Jenkins initiates coverage on Athira Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Corinne Jenkins initiates coverage on Athira Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
